LIVIVO - Search results -

Search results

Result 1 - 10 of total 13

Search options

Article: Identifying Clinical Phenotypes in Moderate to Severe Acute Respiratory Distress Syndrome Related to COVID-19: The COVADIS Study.

Lascarrou, Jean-Baptiste / Gaultier, Aurelie / Soumagne, Thibaud / Serck, Nicolas / Sauneuf, Bertrand / Piagnerelli, Michael / Ly, Andre / Lejeune, Francois / Lefebvre, Laurent / Hraiech, Sami / Horlait, Geoffrey / Higny, Julien / D'hondt, Alain / Gaudry, Stephane / Courcelle, Romain / Carbutti, Giuseppe / Blonz, Gauthier / Ottavy, Gregoire / Aissaoui, Nadia /

Vinsonneau, Christophe / Vandenbunder, Benoit / Textoris, Julien / Szychowiak, Piotr / Grimaldi, David

Frontiers in medicine

2021 Volume 8, Page(s) 632933

Abstract: Objectives: ...

Abstract	Objectives:
Language	English
Publishing date	2021-03-11
Publishing country	Switzerland
Document type	Journal Article
ZDB-ID	2775999-4
ISSN	2296-858X
ISSN	2296-858X
DOI	10.3389/fmed.2021.632933
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

Article ; Online: Perioperative beta-blocker therapy and mortality.

Vandenbunder, Benoit / Mignon, Alexandre

The New England journal of medicine

2005 Volume 353, Issue 23, Page(s) 2513–5; author reply 2513–5

MeSH term(s)	Adrenergic beta-Antagonists/adverse effects ; Adrenergic beta-Antagonists/therapeutic use ; Hospital Mortality ; Humans ; Myocardial Infarction/prevention & control ; Perioperative Care ; Postoperative Complications/mortality ; Postoperative Complications/prevention & control ; Risk ; Surgical Procedures, Operative
Chemical Substances	Adrenergic beta-Antagonists
Language	English
Publishing date	2005-12-08
Publishing country	United States
Document type	Comment ; Letter
ZDB-ID	207154-x
ISSN	1533-4406 ; 0028-4793
ISSN (online)	1533-4406
ISSN	0028-4793
DOI	10.1056/NEJM200512083532319
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Ua VI Zs.34: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: Static compliance of the respiratory system in COVID-19 related ARDS: an international multicenter study.

Critical care (London, England)

2021 Volume 25, Issue 1, Page(s) 52

Abstract: Background: Controversies exist on the nature of COVID-19 related acute respiratory distress syndrome (ARDS) in particular on the static compliance of the respiratory system (Crs). We aimed to analyze the association of Crs with outcome in COVID-19- ... ...

Abstract	Background: Controversies exist on the nature of COVID-19 related acute respiratory distress syndrome (ARDS) in particular on the static compliance of the respiratory system (Crs). We aimed to analyze the association of Crs with outcome in COVID-19-associated ARDS, to ascertain its determinants and to describe its evolution at day-14. Methods: In this observational multicenter cohort of patients with moderate to severe Covid-19 ARDS, Crs was measured at day-1 and day-14. Association between Crs or Crs/ideal body weight (IBW) and breathing without assistance at day-28 was analyzed with multivariable logistic regression. Determinants were ascertained by multivariable linear regression. Day-14 Crs was compared to day-1 Crs with paired t-test in patients still under controlled mechanical ventilation. Results: The mean Crs in 372 patients was 37.6 ± 13 mL/cmH Conclusion: In a large multicenter cohort of moderate to severe COVID-19 ARDS, mean Crs was decreased below 40 mL/cmH
MeSH term(s)	Aged ; COVID-19/complications ; COVID-19/physiopathology ; COVID-19/therapy ; Cohort Studies ; Female ; Humans ; Male ; Middle Aged ; Respiratory Distress Syndrome/etiology ; Respiratory Distress Syndrome/physiopathology ; Respiratory Distress Syndrome/therapy ; SARS-CoV-2/pathogenicity
Language	English
Publishing date	2021-02-08
Publishing country	England
Document type	Journal Article ; Multicenter Study ; Observational Study
ZDB-ID	2041406-7
ISSN	1466-609X ; 1364-8535
ISSN (online)	1466-609X
ISSN	1364-8535
DOI	10.1186/s13054-020-03433-0
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.A 5517: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (2.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: Factors Associated With Pulmonary Embolism Among Coronavirus Disease 2019 Acute Respiratory Distress Syndrome: A Multicenter Study Among 375 Patients.

Soumagne, Thibaud / Lascarrou, Jean-Baptiste / Hraiech, Sami / Horlait, Geoffroy / Higny, Julien / d'Hondt, Alain / Grimaldi, David / Gaudry, Stéphane / Courcelle, Romain / Carbutti, Giuseppe / Blonz, Gauthier / Aissaoui, Nadia / Vinsonneau, Christophe / Vandenbunder, Benoit / Textoris, Julien / Szychowiak, Piotr / Serck, Nicolas / Sauneuf, Bertrand / Piagnerelli, Michael /

Ly, Andre / Lejeune, François / Lefebvre, Laurent / Piton, Gaël

Critical care explorations

2020 Volume 2, Issue 7, Page(s) e0166

Abstract: Risk factors associated with pulmonary embolism in coronavirus disease 2019 acute respiratory distress syndrome patients deserve to be better known. We therefore performed a post hoc analysis from the COronaVirus-Associated DIsease Study (COVADIS) ... ...

Abstract	Risk factors associated with pulmonary embolism in coronavirus disease 2019 acute respiratory distress syndrome patients deserve to be better known. We therefore performed a post hoc analysis from the COronaVirus-Associated DIsease Study (COVADIS) project, a multicenter observational study gathering 21 ICUs from France (
Keywords	covid19
Language	English
Publishing date	2020-06-25
Publishing country	United States
Document type	Journal Article
ISSN	2639-8028
ISSN (online)	2639-8028
DOI	10.1097/CCE.0000000000000166
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Inter-library loan at ZB MED

Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

Article ; Online: Identifying Clinical Phenotypes in Moderate to Severe Acute Respiratory Distress Syndrome Related to COVID-19

Jean-Baptiste Lascarrou / Aurelie Gaultier / Thibaud Soumagne / Nicolas Serck / Bertrand Sauneuf / Michael Piagnerelli / Andre Ly / Francois Lejeune / Laurent Lefebvre / Sami Hraiech / Geoffrey Horlait / Julien Higny / Alain D'hondt / Stephane Gaudry / Romain Courcelle / Giuseppe Carbutti / Gauthier Blonz / Gregoire Ottavy / Nadia Aissaoui /

Christophe Vinsonneau / Benoit Vandenbunder / Julien Textoris / Piotr Szychowiak / David Grimaldi / the COVADIS study group

Frontiers in Medicine, Vol

The COVADIS Study

2021 Volume 8

Abstract: Objectives: Different phenotypes have been identified in acute respiratory distress syndrome (ARDS). Existence of several phenotypes in coronavirus disease (COVID-19) related acute respiratory distress syndrome is unknown. We sought to identify different ...

Abstract	Objectives: Different phenotypes have been identified in acute respiratory distress syndrome (ARDS). Existence of several phenotypes in coronavirus disease (COVID-19) related acute respiratory distress syndrome is unknown. We sought to identify different phenotypes of patients with moderate to severe ARDS related to COVID-19.Methods: We conducted an observational study of 416 COVID-19 patients with moderate to severe ARDS at 21 intensive care units in Belgium and France. The primary outcome was day-28 ventilatory free days. Secondary outcomes were mortality on day 28, acute kidney injury, acute cardiac injury, pulmonary embolism, and deep venous thrombosis. Multiple factor analysis and hierarchical classification on principal components were performed to distinguish different clinical phenotypes.Results: We identified three different phenotypes in 150, 176, and 90 patients, respectively. Phenotype 3 was characterized by short evolution, severe hypoxemia, and old comorbid patients. Phenotype 1 was mainly characterized by the absence of comorbidities, relatively high compliance, and long duration of symptoms, whereas phenotype 2 was characterized female sex, and the presence of mild comorbidities such as uncomplicated diabetes or chronic hypertension. The compliance in phenotype 2 was lower than that in phenotype 1, with higher plateau and driving pressure. Phenotype 3 was associated with higher mortality compared to phenotypes 1 and 2.Conclusions: In COVID-19 patients with moderate to severe ARDS, we identified three clinical phenotypes. One of these included older people with comorbidities who had a fulminant course of disease with poor prognosis. Requirement of different treatments and ventilatory strategies for each phenotype needs further investigation.
Keywords	COVID-19 ; ARDS ; intubation ; mechanical ventilation ; phenotype ; Medicine (General) ; R5-920
Subject code	610
Language	English
Publishing date	2021-03-01T00:00:00Z
Publisher	Frontiers Media S.A.
Document type	Article ; Online
Database	BASE - Bielefeld Academic Search Engine (life sciences selection)

Full text online

Full text

Inter-library loan at ZB MED

Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

Article: Characteristics and outcomes of acute respiratory distress syndrome related to COVID-19 in Belgian and French intensive care units according to antiviral strategies: the COVADIS multicentre observational study.

Grimaldi, David / Aissaoui, Nadia / Blonz, Gauthier / Carbutti, Giuseppe / Courcelle, Romain / Gaudry, Stephane / Gaultier, Aurelie / D'hondt, Alain / Higny, Julien / Horlait, Geoffrey / Hraiech, Sami / Lefebvre, Laurent / Lejeune, Francois / Ly, Andre / Piagnerelli, Michael / Sauneuf, Bertrand / Serck, Nicolas / Soumagne, Thibaud / Szychowiak, Piotr /

Textoris, Julien / Vandenbunder, Benoit / Vinsonneau, Christophe / Lascarrou, Jean- Baptiste

Annals of intensive care

2020 Volume 10, Issue 1, Page(s) 131

Abstract: Background: Limited data are available regarding antiviral therapy efficacy in most severe patients under mechanical ventilation for Covid-19-related acute respiratory distress syndrome (ARDS).: Methods: Comparison of antiviral strategies (none, ... ...

Abstract	Background: Limited data are available regarding antiviral therapy efficacy in most severe patients under mechanical ventilation for Covid-19-related acute respiratory distress syndrome (ARDS). Methods: Comparison of antiviral strategies (none, hydroxychloroquine (OHQ), lopinavir/ritonavir (L/R), others (combination or remdesivir) in an observational multicentre cohort of patients with moderate-to-severe Covid-19 ARDS. The primary endpoint was the number of day 28 ventilator-free days (VFD). Patients who died before d28 were considered as having 0 VFD. The variable was dichotomized into "patients still ventilated or dead at day 28" versus "patients weaned and alive at day 28". Results: We analyzed 415 patients (85 treated with standard of care (SOC), 57 with L/R, 220 with OHQ, and 53 others). The median number of d28-VFD was 0 (IQR 0-13) and differed between groups (P = 0.03), SOC patients having the highest d28-VFD. After adjustment for age, sex, Charlson Comorbidity Index, PaO Conclusion: In this multicentre observational study of moderate-to-severe Covid-19 ARDS patients, we did not observe any benefit among patients treated with OHQ or L/R compared with SOC. The use of L/R treatment was associated with an increased need for RRT. Take home message Neither hydroxychloroquine nor lopinavir/ritonavir as COVID-19 antiviral treatment is associated with higher ventilator-free days at day 28 when compared with standard of care (no antiviral treatment) in ICU patients under invasive mechanical ventilation. Lopinavir/ritonavir is associated with an increased risk of renal replacement therapy requirement. Tweet COVID-19: Insights from ARDS cohort: no signal of efficacy of any antiviral drugs. Lopinavir/ritonavir may be associated with need for RRT.
Keywords	covid19
Language	English
Publishing date	2020-10-06
Publishing country	Germany
Document type	Journal Article
ZDB-ID	2617094-2
ISSN	2110-5820
ISSN	2110-5820
DOI	10.1186/s13613-020-00751-y
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Article ; Online: Characteristics and outcomes of acute respiratory distress syndrome related to COVID-19 in Belgian and French intensive care units according to antiviral strategies

David Grimaldi / Nadia Aissaoui / Gauthier Blonz / Giuseppe Carbutti / Romain Courcelle / Stephane Gaudry / Aurelie Gaultier / Alain D’hondt / Julien Higny / Geoffrey Horlait / Sami Hraiech / Laurent Lefebvre / Francois Lejeune / Andre Ly / Michael Piagnerelli / Bertrand Sauneuf / Nicolas Serck / Thibaud Soumagne / Piotr Szychowiak /

Julien Textoris / Benoit Vandenbunder / Christophe Vinsonneau / Jean- Baptiste Lascarrou / for the COVADIS study group

Annals of Intensive Care, Vol 10, Iss 1, Pp 1-

the COVADIS multicentre observational study

2020 Volume 11

Abstract: Abstract Background Limited data are available regarding antiviral therapy efficacy in most severe patients under mechanical ventilation for Covid-19-related acute respiratory distress syndrome (ARDS). Methods Comparison of antiviral strategies (none, ... ...

Abstract	Abstract Background Limited data are available regarding antiviral therapy efficacy in most severe patients under mechanical ventilation for Covid-19-related acute respiratory distress syndrome (ARDS). Methods Comparison of antiviral strategies (none, hydroxychloroquine (OHQ), lopinavir/ritonavir (L/R), others (combination or remdesivir) in an observational multicentre cohort of patients with moderate-to-severe Covid-19 ARDS. The primary endpoint was the number of day 28 ventilator-free days (VFD). Patients who died before d28 were considered as having 0 VFD. The variable was dichotomized into “patients still ventilated or dead at day 28” versus “patients weaned and alive at day 28”. Results We analyzed 415 patients (85 treated with standard of care (SOC), 57 with L/R, 220 with OHQ, and 53 others). The median number of d28-VFD was 0 (IQR 0–13) and differed between groups (P = 0.03), SOC patients having the highest d28-VFD. After adjustment for age, sex, Charlson Comorbidity Index, PaO2/FiO2 ratio and plateau pressure and accounting for center effect with a generalized linear mixed model, none of the antiviral strategies increased the chance of being alive and weaned from MV at day 28 compared to the SOC strategy (OR 0.48 CI95% (0.18–1.25); OR 0.96 (0.47–2.02) and OR 1.43 (0.53–4.04) for L/R, OHQ and other treatments, respectively). Acute kidney injury during ICU stay was frequent (55%); its incidence was higher in patients receiving lopinavir (66 vs 53%, P = 0.03). After adjustment for age, sex, BMI, chronic hypertension and chronic renal disease, the use of L/R was associated with an increased risk of renal replacement therapy (RRT). (OR 2.52 CI95% 1.16–5.59). Conclusion In this multicentre observational study of moderate-to-severe Covid-19 ARDS patients, we did not observe any benefit among patients treated with OHQ or L/R compared with SOC. The use of L/R treatment was associated with an increased need for RRT. Take home message Neither hydroxychloroquine nor lopinavir/ritonavir as COVID-19 antiviral treatment is associated with higher ventilator-free days at day 28 when compared with standard of care (no antiviral treatment) in ICU patients under invasive mechanical ventilation. Lopinavir/ritonavir is associated with an increased risk of renal replacement therapy requirement. Tweet COVID-19: Insights from ARDS cohort: no signal of efficacy of any antiviral drugs. Lopinavir/ritonavir may be associated with need for RRT
Keywords	Renal replacement therapy ; Remdesivir ; Lopinavir ; Ritonavir ; Acute kidney injury ; Hydroxychloroquine ; Medical emergencies. Critical care. Intensive care. First aid ; RC86-88.9 ; covid19
Subject code	610
Language	English
Publishing date	2020-10-01T00:00:00Z
Publisher	SpringerOpen
Document type	Article ; Online
Database	BASE - Bielefeld Academic Search Engine (life sciences selection)

Full text online

Full text

Inter-library loan at ZB MED

Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

Article ; Online: A charter for biomedical research ethics in a progressive, caring society.

Vandoolaeghe, Sylvie / Blaizot, Alessandra / Boudiguet, Danie / Bougault, Valérie / Dei Cas, Eduardo / Foligne, Benoît / Goffard, Anne / Lefranc, Hélène / Oxombre, Bénédicte / Trentesaux, Thomas / Vandenbunder, Bernard / Wolowczuk, Isabelle / Delhaes, Laurence

Philosophy, ethics, and humanities in medicine : PEHM

2015 Volume 10, Page(s) 12

Abstract: Background: Given that advances in research continuously raise new ethical issues, a multidisciplinary working group of investigators involved in biomedical research has gathered to discuss and compare ethical viewpoints in their daily practice.: ... ...

Abstract	Background: Given that advances in research continuously raise new ethical issues, a multidisciplinary working group of investigators involved in biomedical research has gathered to discuss and compare ethical viewpoints in their daily practice. Methods: The working group has drafted a Charter for Ethics in Biomedical Research that encompasses all the steps in the research process, i.e. from the initial idea to analysis and publication of the results. Results: Based on key principles for ethically responsible research, the Charter may serve as a tool for performing research, discussing research issues and training researchers. Conclusions: The Charter should stimulate researchers to think about their responsibility for research in a progressive, caring society.
MeSH term(s)	Biomedical Research/ethics ; Consensus ; Databases, Factual ; Group Processes ; Humans
Language	English
Publishing date	2015-11-13
Publishing country	England
Document type	Journal Article
ISSN	1747-5341
ISSN (online)	1747-5341
DOI	10.1186/s13010-015-0032-y
Database	MEDical Literature Analysis and Retrieval System OnLINE

Full text online

Full text

Order via subito

Inter-library loan at ZB MED

Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

Details ▾
- Full text online
- Order with fees

Article: Factors Associated With Pulmonary Embolism Among Coronavirus Disease 2019 Acute Respiratory Distress Syndrome: A Multicenter Study Among 375 Patients

Soumagne, Thibaud / Lascarrou, Jean-Baptiste / Hraiech, Sami / Horlait, Geoffroy / Higny, Julien / d039, / Hondt, Alain / Grimaldi, David / Gaudry, Stéphane / Courcelle, Romain / Carbutti, Giuseppe / Blonz, Gauthier / Aissaoui, Nadia / Vinsonneau, Christophe / Vandenbunder, Benoit / Textoris, Julien / Szychowiak, Piotr / Serck, Nicolas / Sauneuf, Bertrand /

Piagnerelli, Michael / Ly, Andre / Lejeune, François / Lefebvre, Laurent / Piton, Gaël

Crit Care Explor

Abstract	Risk factors associated with pulmonary embolism in coronavirus disease 2019 acute respiratory distress syndrome patients deserve to be better known. We therefore performed a post hoc analysis from the COronaVirus-Associated DIsease Study (COVADIS) project, a multicenter observational study gathering 21 ICUs from France (n = 12) and Belgium (n = 9). Three-hundred seventy-five consecutive patients with moderate-to-severe acute respiratory distress syndrome and positive coronavirus disease 2019 were included in the study. At day 28, 15% were diagnosed with pulmonary embolism. Known risk factors for pulmonary embolism including cancer, obesity, diabetes, hypertension, and coronary artery disease were not associated with pulmonary embolism. In the multivariate analysis, younger age (< 65 yr) (odds ratio, 2.14; 1.17-4.03), time between onset of symptoms and antiviral administration greater than or equal to 7 days (odds ratio, 2.39; 1.27-4.73), and use of neuromuscular blockers greater than or equal to 7 days (odds ratio, 1.89; 1.05-3.43) were independently associated with pulmonary embolism. These new findings reinforce the need for prospective studies that will determine the predictors of pulmonary embolism among patients with severe coronavirus disease 2019.
Keywords	covid19
Publisher	WHO
Document type	Article
Note	WHO #Covidence: #620926
Database	COVID19

Inter-library loan at ZB MED

Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

Details ▾

Article ; Online: Characteristics and outcomes of acute respiratory distress syndrome related to COVID-19 in Belgian and French intensive care units according to antiviral strategies

Textoris, Julien / Vandenbunder, Benoit / Vinsonneau, Christophe / Lascarrou, Jean- Baptiste / COVADIS study group

Annals of intensive care, Vol. 10, no.1, p.

the COVADIS multicentre observational study.

2020 Volume 131

Abstract: Limited data are available regarding antiviral therapy efficacy in most severe patients under mechanical ventilation for Covid-19-related acute respiratory distress syndrome (ARDS). Comparison of antiviral strategies (none, hydroxychloroquine (OHQ), ... ...

Abstract	Limited data are available regarding antiviral therapy efficacy in most severe patients under mechanical ventilation for Covid-19-related acute respiratory distress syndrome (ARDS). Comparison of antiviral strategies (none, hydroxychloroquine (OHQ), lopinavir/ritonavir (L/R), others (combination or remdesivir) in an observational multicentre cohort of patients with moderate-to-severe Covid-19 ARDS. The primary endpoint was the number of day 28 ventilator-free days (VFD). Patients who died before d28 were considered as having 0 VFD. The variable was dichotomized into "patients still ventilated or dead at day 28" versus "patients weaned and alive at day 28". We analyzed 415 patients (85 treated with standard of care (SOC), 57 with L/R, 220 with OHQ, and 53 others). The median number of d28-VFD was 0 (IQR 0-13) and differed between groups (P = 0.03), SOC patients having the highest d28-VFD. After adjustment for age, sex, Charlson Comorbidity Index, PaO/FiO ratio and plateau pressure and accounting for center effect with a generalized linear mixed model, none of the antiviral strategies increased the chance of being alive and weaned from MV at day 28 compared to the SOC strategy (OR 0.48 CI95% (0.18-1.25); OR 0.96 (0.47-2.02) and OR 1.43 (0.53-4.04) for L/R, OHQ and other treatments, respectively). Acute kidney injury during ICU stay was frequent (55%); its incidence was higher in patients receiving lopinavir (66 vs 53%, P = 0.03). After adjustment for age, sex, BMI, chronic hypertension and chronic renal disease, the use of L/R was associated with an increased risk of renal replacement therapy (RRT). (OR 2.52 CI95% 1.16-5.59). In this multicentre observational study of moderate-to-severe Covid-19 ARDS patients, we did not observe any benefit among patients treated with OHQ or L/R compared with SOC. The use of L/R treatment was associated with an increased need for RRT. Take home message Neither hydroxychloroquine nor lopinavir/ritonavir as COVID-19 antiviral treatment is associated with higher ventilator-free days at day 28 when compared with standard of care (no antiviral treatment) in ICU patients under invasive mechanical ventilation. Lopinavir/ritonavir is associated with an increased risk of renal replacement therapy requirement. Tweet COVID-19: Insights from ARDS cohort: no signal of efficacy of any antiviral drugs. Lopinavir/ritonavir may be associated with need for RRT.
Keywords	Acute kidney injury ; Hydroxychloroquine ; Lopinavir ; Remdesivir ; Renal replacement therapy ; Ritonavir ; covid19
Language	English
Publishing country	be
Document type	Article ; Online
Database	BASE - Bielefeld Academic Search Engine (life sciences selection)

Full text online

Full text

Inter-library loan at ZB MED

Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

To top

More links

Kategorien

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

Order via subito

Inter-library loan at ZB MED

Full text online

More links

Kategorien

Inter-library loan at ZB MED

More links

Kategorien

Order via subito

Full text online

More links

Kategorien

Inter-library loan at ZB MED

Full text online

More links

Kategorien

Order via subito

Inter-library loan at ZB MED

Kategorien

Inter-library loan at ZB MED

Full text online

More links

Kategorien

Inter-library loan at ZB MED